Market Cap 38.07B
Revenue (ttm) 15.12B
Net Income (ttm) 1.47B
EPS (ttm) N/A
PE Ratio 16.66
Forward PE 16.68
Profit Margin 9.72%
Debt to Equity Ratio 0.67
Volume 11,433,500
Avg Vol 20,614,148
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 98%
Beta 0.47
Analysts Sell
Price Target $19.00

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 908 874 1200
Address:
1 Kenvue Way, Summit, United States
TonyG6ix
TonyG6ix Jul. 2 at 6:13 PM
$KVUE still in it, I've got another 700 in other accounts.
0 · Reply
ApexEquityVault
ApexEquityVault Jul. 2 at 4:10 PM
$KVUE 10 JUL 26 $20 CALL $0.15 ADDING HEAVY + SWING TRADE + CLOSE TO IN THE MONEY + GAP FILL PLAY + SHORT SQUEEZE POTENTIAL NEXT WEEK CONTRACTS
0 · Reply
liamsniperalert
liamsniperalert Jul. 2 at 4:02 PM
$KVUE 10 JUL 26 $20 CALL $0.15
0 · Reply
StockpeakHQ_1
StockpeakHQ_1 Jul. 2 at 4:02 PM
$KVUE 10 JUL 26 $20 CALL $0.15
0 · Reply
Blockwave1
Blockwave1 Jul. 2 at 4:01 PM
$KVUE 🌊 10 JUL 26 $20 CALL $0.15 ADDING HEAVY + SWING TRADE + CLOSE TO IN THE MONEY + GAP FILL PLAY + SHORT SQUEEZE POTENTIAL
2 · Reply
Buy_Last_Dip
Buy_Last_Dip Jul. 2 at 1:55 PM
$KVUE conversion at 2nd half of 2026. So can be now till end of the year. Anyone have an estimate?
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 2 at 8:01 AM
$KVUE Share Price: $19.35 Contract Selected: Jul 24, 2026 $20 Calls Buy Zone: $0.10 – $0.12 Target Zone: $0.16 – $0.20 Potential Upside: 56% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 29 at 11:53 PM
$KVUE Current Stock Price: $19.09 Contracts to trade: $19.0 KVUE Jul 02 2026 Call Entry: $0.04 Exit: $0.05 ROI: 28% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 26 at 4:25 PM
$KVUE Current Stock Price: $19.05 Contracts to trade: $19.0 KVUE Jun 26 2026 Call Entry: $0.05 Exit: $0.07 ROI: 34% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
thomos
thomos Jun. 26 at 4:09 PM
$KVUE 07/02 | 19.5 CALL Entry: $0.04 💊📈🔥
0 · Reply
Latest News on KVUE
Kenvue Transcript: AGM 2026

May 21, 2026, 9:00 AM EDT - 6 weeks ago

Kenvue Transcript: AGM 2026


Kenvue Earnings release: Q1 2026

May 7, 2026, 9:30 AM EDT - 2 months ago

Kenvue Earnings release: Q1 2026


Kenvue Quarterly report: Q1 2026

May 7, 2026, 9:30 AM EDT - 2 months ago

Kenvue Quarterly report: Q1 2026


Kenvue reports Q1 adjusted EPS 32c, consensus 26c

2026-05-07T11:12:08.000Z - 2 months ago

Kenvue reports Q1 adjusted EPS 32c, consensus 26c


Kenvue Reports First Quarter 2026 Results

May 7, 2026, 6:30 AM EDT - 2 months ago

Kenvue Reports First Quarter 2026 Results


Kenvue Declares Quarterly Cash Dividend

Apr 29, 2026, 6:45 AM EDT - 2 months ago

Kenvue Declares Quarterly Cash Dividend


Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Apr 23, 2026, 4:32 PM EDT - 2 months ago

Kenvue to Announce First Quarter 2026 Results on May 7, 2026


Kenvue price target lowered to $19 from $20 at Citi

2026-04-15T10:40:06.000Z - 2 months ago

Kenvue price target lowered to $19 from $20 at Citi


Kenvue price target lowered to $18 from $19 at Barclays

2026-04-14T13:08:51.000Z - 2 months ago

Kenvue price target lowered to $18 from $19 at Barclays


Tylenol in pregnancy not linked with autism, Danish study finds

Apr 13, 2026, 2:09 PM EDT - 2 months ago

Tylenol in pregnancy not linked with autism, Danish study finds


Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Kenvue Proxy statement: Proxy filing


Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Kenvue Proxy statement: Proxy filing


Kenvue price target lowered to $18 from $19 at UBS

2026-04-07T11:09:21.000Z - 3 months ago

Kenvue price target lowered to $18 from $19 at UBS


Tylenol use among women dropped after Trump tied it to autism

Mar 6, 2026, 12:43 PM EST - 4 months ago

Tylenol use among women dropped after Trump tied it to autism


Kenvue price target raised to $19 from $18 at Barclays

2026-03-06T10:52:41.000Z - 4 months ago

Kenvue price target raised to $19 from $18 at Barclays


Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Feb 26, 2026, 11:14 AM EST - 4 months ago

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol


Kenvue rumor highlighted in Betaville blog

2026-02-20T20:31:01.000Z - 4 months ago

Kenvue rumor highlighted in Betaville blog


Kenvue price target raised to $19 from $17 at UBS

2026-02-18T12:46:01.000Z - 4 months ago

Kenvue price target raised to $19 from $17 at UBS


Kenvue price target raised to $18 from $17 at Canaccord

2026-02-18T12:17:16.000Z - 4 months ago

Kenvue price target raised to $18 from $17 at Canaccord


Kenvue price target raised to $20 from $18 at Citi

2026-02-18T11:35:35.000Z - 4 months ago

Kenvue price target raised to $20 from $18 at Citi


Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:50 PM EST - 4 months ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal


Kenvue reports Q4 EPS 27c, consensus 22c

2026-02-17T21:50:45.000Z - 4 months ago

Kenvue reports Q4 EPS 27c, consensus 22c


Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:45 PM EST - 4 months ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results


Kenvue Annual report: Q4 2025

Feb 17, 2026, 4:00 PM EST - 4 months ago

Kenvue Annual report: Q4 2025


Kenvue Earnings release: Q4 2025

Feb 17, 2026, 4:00 PM EST - 4 months ago

Kenvue Earnings release: Q4 2025


Kenvue Transcript: AGM 2026

Jan 29, 2026, 9:00 AM EST - 5 months ago

Kenvue Transcript: AGM 2026


Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

Jan 27, 2026, 6:40 AM EST - 5 months ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB


Kenvue Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 7 months ago

Kenvue Proxy statement: Proxy Filing


US appeals court to weigh reviving cases over Tylenol and autism

Nov 17, 2025, 6:07 AM EST - 8 months ago

US appeals court to weigh reviving cases over Tylenol and autism


Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 8 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit


Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 8 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB


Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 8 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB


Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Nov 3, 2025, 9:30 AM EST - 8 months ago

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal


TonyG6ix
TonyG6ix Jul. 2 at 6:13 PM
$KVUE still in it, I've got another 700 in other accounts.
0 · Reply
ApexEquityVault
ApexEquityVault Jul. 2 at 4:10 PM
$KVUE 10 JUL 26 $20 CALL $0.15 ADDING HEAVY + SWING TRADE + CLOSE TO IN THE MONEY + GAP FILL PLAY + SHORT SQUEEZE POTENTIAL NEXT WEEK CONTRACTS
0 · Reply
liamsniperalert
liamsniperalert Jul. 2 at 4:02 PM
$KVUE 10 JUL 26 $20 CALL $0.15
0 · Reply
StockpeakHQ_1
StockpeakHQ_1 Jul. 2 at 4:02 PM
$KVUE 10 JUL 26 $20 CALL $0.15
0 · Reply
Blockwave1
Blockwave1 Jul. 2 at 4:01 PM
$KVUE 🌊 10 JUL 26 $20 CALL $0.15 ADDING HEAVY + SWING TRADE + CLOSE TO IN THE MONEY + GAP FILL PLAY + SHORT SQUEEZE POTENTIAL
2 · Reply
Buy_Last_Dip
Buy_Last_Dip Jul. 2 at 1:55 PM
$KVUE conversion at 2nd half of 2026. So can be now till end of the year. Anyone have an estimate?
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 2 at 8:01 AM
$KVUE Share Price: $19.35 Contract Selected: Jul 24, 2026 $20 Calls Buy Zone: $0.10 – $0.12 Target Zone: $0.16 – $0.20 Potential Upside: 56% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 29 at 11:53 PM
$KVUE Current Stock Price: $19.09 Contracts to trade: $19.0 KVUE Jul 02 2026 Call Entry: $0.04 Exit: $0.05 ROI: 28% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 26 at 4:25 PM
$KVUE Current Stock Price: $19.05 Contracts to trade: $19.0 KVUE Jun 26 2026 Call Entry: $0.05 Exit: $0.07 ROI: 34% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
thomos
thomos Jun. 26 at 4:09 PM
$KVUE 07/02 | 19.5 CALL Entry: $0.04 💊📈🔥
0 · Reply
TragicRain
TragicRain Jun. 24 at 11:33 AM
$KVUE - Question, does this price have a cap on it because of the pending merger? I know this ticker is technically tied to $KMB was curious if anyone has the math on it - I think its like $21 or something.....
1 · Reply
SuperGreenToday
SuperGreenToday Jun. 23 at 3:53 PM
$KVUE Share Price: $18.27 Contract Selected: Jul 17, 2026 $20 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 68% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ItTakes2toContango
ItTakes2toContango Jun. 17 at 11:54 PM
$FAST $GE $JPM $KVUE $SO This was an excellent post. I bought all of them and GE is +20% and JPM +10% in a month. 👍
0 · Reply
Bazziggr
Bazziggr Jun. 17 at 7:01 PM
$KVUE join with VITL
0 · Reply
Suite510
Suite510 Jun. 17 at 2:10 PM
$JNJ $KVUE $SPX June 16, 2026 😬💰 J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case A Minnesota state judge on Monday upheld a $65.5 million verdict awarded to a mother of three children who had claimed that Johnson & Johnson's talc products exposed her to asbestos and contributed to her cancer, saying that the jury's decision was supported by the evidence at trial.
1 · Reply
OnlyFibs
OnlyFibs Jun. 14 at 6:38 PM
$KVUE testing trendline resistance. Break $18+ on volume, and the trend shift is confirmed. Defensive quality for the volatility-prone market. 📈 🐂 Bull: $18.15+ 🐻 Bear: $16.50 #KVUE #Kenvue #Trading #hovdid
0 · Reply
OnlyFibs
OnlyFibs Jun. 13 at 7:09 PM
$KVUE has finally reclaimed its major weekly moving averages, marking a technical shift from a year-long downtrend to a potential new upward cycle. The Q1 earnings beat proved the core business is resilient, and the market is slowly starting to look past the Kimberly-Clark acquisition uncertainty. If the technical momentum holds, we are staring at a structural trend reversal. 🐂 Bull Level: Hold $17.50 as the primary support floor for a run toward $19.50+. 🐻 Bear Level: $17.00 must hold, or the reversal thesis faces a major delay. #KVUE #Kenvue #StockMarket #TechnicalAnalysis #hovdid
0 · Reply
Suite510
Suite510 Jun. 11 at 2:46 AM
$JNJ $KVUE $SPX oh darn it, more news 🗞️ J&J Talc Claimants Win OK For UK Group Asbestos Suit By Joanne Faulkner June 10, 2026, 12:19 PM BST Thousands of women were granted permission on Wednesday to join together in litigation accusing Johnson & Johnson of knowingly selling baby powder in the U.K. that was contaminated with asbestos....
2 · Reply
Suite510
Suite510 Jun. 11 at 1:38 AM
$JNJ $SPX $KVUE Whoops 😬 another Big “L” J&J Hit With $32M Verdict In LA Baby Powder Cancer TrialA Los Angeles jury Tuesday awarded $32 million to the family of a woman who died of mesothelioma and who said she used Johnson's Baby Powder on herself and her children for decades, finding the product was a substantial factor in causing her illness.
0 · Reply
WuTangClam
WuTangClam Jun. 5 at 3:14 PM
$SPY rotation !! $KMB $KVUE $PG
1 · Reply
Suite510
Suite510 Jun. 5 at 11:00 AM
$ABT $JNJ $KVUE $SPX Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak is Money' lol 🤠🍿
1 · Reply
Suite510
Suite510 Jun. 4 at 5:20 PM
$BAYRY $JNJ $KVUE $SPX You ready? 🤠🍿 June 03, 2026 'This Is Their Document': Jury Told J&J Docs Prove Talc Lies Counsel for the families of three women who died of ovarian cancer delivered closing arguments Wednesday in their six-week-long bellwether lawsuit against Johnson & Johnson, telling jurors that decades-old internal documents prove the company hid that its talc was contaminated with asbestos.
1 · Reply